Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
TowneBank to Acquire blueharbor bank for $154 Million

TowneBank to Acquire blueharbor bank for $154 Million

MT newswireMT newswire2026/10/06 13:00

09:00 AM EDT, 10/06/2026 (MT Newswires) -- TowneBank (TOWN) has agreed to acquire blueharbor bank for about $154 million, the companies said Tuesday. Under the terms of the deal, shareholders of blueharbor will receive $12.70 in cash and 1.0534 TowneBank common shares for each outstanding blueharbor share they own, for an implied value of $50.78 per share. The total consideration mix results in around 75% of the transaction paid in TowneBank common stock. The transaction is expected to close in Q1 2027. Upon closing of the acquisition, blueharbor Chairman Kelley Earnhardt Miller will join the TowneBank board, and blueharbor President and Chief Executive Officer Jim Marshall will become TowneBank's Piedmont regional president.

09:00 AM EDT, 10/06/2026 (MT Newswires) -- TowneBank (TOWN) has agreed to acquire blueharbor bank for about $154 million, the companies said Tuesday. Under the terms of the deal, shareholders of blueharbor will receive $12.70 in cash and 1.0534 TowneBank common shares for each outstanding blueharbor share they own, for an implied value of $50.78 per share. The total consideration mix results in around 75% of the transaction paid in TowneBank common stock. The transaction is expected to close in Q1 2027. Upon closing of the acquisition, blueharbor Chairman Kelley Earnhardt Miller will join the TowneBank board, and blueharbor President and Chief Executive Officer Jim Marshall will become TowneBank's Piedmont regional president.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21